FCMD

Last Update:2016-05-20

FCMD encodes glycosyltransferase-like protein, and is considered as a causal gene of the Fukuyama congenital muscular dystrophy (FCMD). The gene-knockout mice exhibit glycan structure alteration of α−dystroglycan. FCMD synthesizes the Rbo5P structure (Rbo5P-3GalNAcb1-3GlcNAcb1-4(phospho)Man-Ser/Thr), the origin of the tandem repeats of ribitol 5-phosphate (Rbo5P) in the O-mannose glycan structure of α−dystroglycan. The substrate sugar nucleotide, cytidine diphosphate ribitol (CDP- Rbo) is synthesized by isoprenoid synthase domain-containing protein (ISPD), which is also known as a causative gene of muscular dystrophy.

Keyword: Fukuyama congenital muscular dystrophy ,  glycosyltransferase-like protein ,  ribitol 5-phosphate ,  α−dystroglycan

CDP-Rbo
JCGG-STR033507 JCGG-STR033528

Glycosyltransferase-like


GGDB Symbol FCMD    Alias
DesignationFukuyama type congenital muscular dystrophy (fukutin)
OrganismHomo sapiens
GeneID 2218
HGNC FKTN (3622)
mRNA NM_006731
map9q31-q33
Protein NP_006722
EC#    
CAZy
GlyCosmos Glycogenes FCMD
OMIM 607440
Disease name CMD1X ,  Dilated cardiomyopathy ,  FCMD ,  Fukuyama congenital muscular dystrophy ,  LGMD2M ,  Limb-girdle muscular dystrophy type 2M
GDGDB CON00378    CON00379    CON00380   
Human Protein Atlas ENSG00000106692
Open ALL Close ALL

Orthologous Gene

Acceptor Substrates (Reference)

Acceptor Substrates (KEM-C)

Expression

RNA Expression from Human Protein Atlas
This RNA expression data uses "HPA data" from the Human Protein Atlas. Tissue RNA Expression

data available from v22.proteinatlas.org

Expression (Reference)

Gene Ontology

This page does not indicate all of the enzymatic reaction, and expression of "FCMD".